x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Johns Hopkins Medicine

Johns Hopkins Medicine

Explore health topics, medical research, education programs and patient stories from Johns Hopkins Medicine in Baltimore, Maryland.

health & fitness medicine

All Episodes

1:04

Why don’t people who are eligible for cholesterol...

Johns Hopkins Medicine ·

2025/07/14

Only about 25 percent of people who need cholesterol lowering medicines based on blood tests take them, with about 2/3 of those who’ve had a cardiovascular event doing so, a study by Caleb Alexander, a drug safety and efficacy expert at … Why don’t people who are eligible for cholesterol lowering medicines take them? Elizabeth Tracey reports Read More »

en-US

1:07

Just how much does it cost our healthcare system when...

Johns Hopkins Medicine ·

2025/07/14

Not taking medicines to lower cholesterol when you clearly need them increases your risk for heart attacks, strokes and other cardiovascular events. Yet a study by Caleb Alexander, a drug safety and efficacy expert at Johns Hopkins, and colleagues, shows … Just how much does it cost our healthcare system when people don’t take needed medicines to reduce cardiovascular risk? Elizabeth Tracey reports Read More »

en-US

1:05

The gap between recommendations and who is actually...

Johns Hopkins Medicine ·

2025/07/14

Cardiovascular disease, including heart attacks and strokes, remains the number one cause of death in the United States, yet many people who should be taking medicines to lower their risk by lowering cholesterol aren’t. That’s according to a study by … The gap between recommendations and who is actually taking medicines to lower cardiovascular disease risk is huge, Elizabeth Tracey reports Read More »

en-US

1:05

How many people aren’t taking needed medicines to...

Johns Hopkins Medicine ·

2025/07/14

Most people have heard of statins, drugs that lower cholesterol and consequent cardiovascular disease risk. Caleb Alexander, a drug safety and efficacy expert at Johns Hopkins, and colleagues, have looked at just how many people who should be taking such … How many people aren’t taking needed medicines to reduce cardiovascular risk? Elizabeth Tracey reports Read More »

en-US

16:39

Episode 68: Appendix E – 5th Edition (Part 6) | Johns...

Johns Hopkins Medicine ·

2025/07/10

Maddie Whalen, Evidence-Based Practice Program Coordinator for the Center for Nursing Inquiry joins Heather Watson, Johns Hopkins Health System Nurse Scientist to cover the Appendix E tools: E1, E2, E3. Appendix E includes appraisal templates for a variety of evidence … Episode 68: Appendix E – 5th Edition (Part 6) | Johns Hopkins Center for Nursing Inquiry Read More »

en-US

5:53

Episode 67: Appendix D – 5th Edition (Part 5) |...

Johns Hopkins Medicine ·

2025/07/10

We’re up to part 5 in our series – Appendix D, or the Appraisal Tool Selection Algorithm. Kim Bissett, EBP Coordinator for the Institute for Johns Hopkins Nursing is back to explain to Heather Watson, Nurse Scientist for the Johns … Episode 67: Appendix D – 5th Edition (Part 5) | Johns Hopkins Center for Nursing Inquiry Read More »

en-US

9:06

Cancer Headlines with William Nelson, Director of the...

Johns Hopkins Medicine ·

2025/06/17

Colorectal cancer screening, and rise in younger people, microplastics and cancer, immune checkpoint inhibitors and longterm toxicity, AI contributions to precision oncology and flattening of breast cancer survival rates.

en-US

1:06

Who is suitable for a breathlessness clinic visit?...

Johns Hopkins Medicine ·

2025/06/16

Breathlessness clinic is a new approach at Johns Hopkins to assist people with chronic lung diseases to live their best lives with these often debilitating conditions. Anna Gersten, a lung expert and director of the clinic, explains who would benefit. … Who is suitable for a breathlessness clinic visit? Elizabeth Tracey reports Read More »

en-US

1:03

What is a breathlessness clinic? Elizabeth Tracey...

Johns Hopkins Medicine ·

2025/06/16

Being short of breath is a terrible feeling, most people agree, and it’s a feature of many lung diseases, especially as they progress. Lung expert Anna Gersten at Johns Hopkins describes how a breathlessness clinic came to be at Hopkins … What is a breathlessness clinic? Elizabeth Tracey reports Read More »

en-US

1:05

What are current studies doing when high levels of...

Johns Hopkins Medicine ·

2025/06/16

High blood biomarkers for Alzheimer’s disease found by the newly FDA approved blood test indicate the presence of two proteins in the brain called amyloid and tau. Abhay Moghakar, a neurologist and blood biomarkers expert at Johns Hopkins, says some … What are current studies doing when high levels of blood biomarkers for Alzheimer’s are found? Elizabeth Tracey reports Read More »

en-US

1:05

What are your options if a new blood test says you...

Johns Hopkins Medicine ·

2025/06/16

Let’s say you’ve taken the newly approved blood test for Alzheimer’s disease and the results indicate the presence of tau and amyloid in your brain, so you’re at risk. Abhay Moghakar, a neurologist and blood biomarkers expert at Johns Hopkins, says … What are your options if a new blood test says you are at risk for Alzheimer’s disease? Elizabeth Tracey reports Read More »

en-US

1:06

People who develop dementia as they age most often...

Johns Hopkins Medicine ·

2025/06/16

You may have heard of a new blood test for Alzheimer’s disease just approved by the FDA. Abhay Moghakar, a neurologist and blood biomarkers expert at Johns Hopkins, says even if you are older and have symptoms of the disease, … People who develop dementia as they age most often have a mixed type, Elizabeth Tracey reports Read More »

en-US

1:06

A truly comprehensive test for Alzheimer’s disease...

Johns Hopkins Medicine ·

2025/06/09

A new blood test for Alzheimer’s disease isn’t a stand alone diagnostic tool. That’s according to Abhay Moghekar, a blood biomarkers expert and a neurologist at Johns Hopkins. Moghekar: You would still need the clinical input in the context of … A truly comprehensive test for Alzheimer’s disease may be on the horizon, Elizabeth Tracey reports Read More »

en-US

1:05

A protein that’s made in your brain at night helps...

Johns Hopkins Medicine ·

2025/06/02

NPTX2 is a protein that’s pivotal for helping your brain decide to remember certain things and forget others, and when levels of it decline it suggests that neurodegenerative processes like dementia may be beginning. That’s according to research by Paul … A protein that’s made in your brain at night helps you remember things, Elizabeth Tracey reports Read More »

en-US

1:05

How do neurodegenerative diseases begin? Elizabeth...

Johns Hopkins Medicine ·

2025/06/02

Many theories on how brain disorders like Alzheimer’s disease begin point to proteins called amyloid beta and tau as accumulating and disrupting the function of neurons. Research by neuroscientist Paul Worley and colleagues at Johns Hopkins points to declining levels … How do neurodegenerative diseases begin? Elizabeth Tracey reports Read More »

en-US

1:01

A change in a protein in the brain signals possible...

Johns Hopkins Medicine ·

2025/06/02

You probably know how complex your brain function is, relying on a delicately balanced system full of proteins that act as signals and specialized nerve and structural cells. Turns out there is an interplay of some neurons being shut down … A change in a protein in the brain signals possible neurocognitive disorders, Elizabeth Tracey reports Read More »

en-US

1:01

Accurately predicting who’s at risk to develop...

Johns Hopkins Medicine ·

2025/06/02

NPTX2 is the abbreviation for a protein found in the brain that may allow much more accurate prognosis of who’s at risk for developing neurocognitive disorders, including Alzheimer’s disease and other dementias. That’s according to Johns Hopkins neuroscientist Paul Worley, … Accurately predicting who’s at risk to develop Alzheimer’s disease may now be easier, Elizabeth Tracey reports Read More »

en-US

1:06

What can proteins in the blood and elsewhere teach us...

Johns Hopkins Medicine ·

2025/06/02

Proteins known as tau and beta amyloid have been part of the dialogue on Alzheimer’s disease development for many years, with methods to measure them and drugs to remove them active areas of research. Another protein involved in the process … What can proteins in the blood and elsewhere teach us about developing dementia? Elizabeth Tracey reports Read More »

en-US

11:10

Cancer Headlines with William Nelson, MD

Johns Hopkins Medicine ·

2025/05/12

This month's topics include using symptom monitoring remotely to inform care of people with advanced cancer, painful neuropathy after some types of chemotherapy, best strategies for treating esophagus cancer, urinary DNA methylation testing for bladder cancer diagnosis.

en-US

1:04

How is poor air quality related to dry air and...

Johns Hopkins Medicine ·

2025/05/12

Very tiny particles known as PM2.5 are a part of pollutants in the air, and have been shown to negatively affect health. Ditto for warming temperatures, which dry out our respiratory system, research by David Edwards, a respiratory health expert … How is poor air quality related to dry air and respiratory health? Elizabeth Tracey reports Read More »

en-US

204 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown